Skip to main content

Most Moms-to-Be Interested in RSV Vaccination During Pregnancy

Medically reviewed by Carmen Pope, BPharm. Last updated on April 25, 2024.

By Elana Gotkine HealthDay Reporter

THURSDAY, April 25, 2024 -- More than half of women who are pregnant or planning to become pregnant are very likely to get vaccinated against respiratory syncytial virus (RSV) during pregnancy, according to a study published online April 25 in Pediatrics.

Jennifer K. Saper, M.D., from the Ann & Robert H. Lurie Children's Hospital of Chicago, and colleagues characterized interest in RSV vaccination during pregnancy among women who were pregnant or planning to become pregnant. A cross-sectional online survey was conducted among individuals aged 18 to 45 years who were currently pregnant or trying to become pregnant in March 2023.

Overall, 1,528 of the 1,619 completed surveys were analyzed. The researchers found that 54 percent of respondents indicated being "very likely" to get vaccinated against RSV during pregnancy. The strongest predictor of vaccination likelihood was the perception of RSV as a serious illness. Predicted proportions of those "very likely" to vaccinate against RSV followed a similar pattern in the full regression model (63, 55, and 35 percent if RSV infection was perceived as serious and likely, serious and unlikely, and not serious, respectively).

"Educational efforts about protection against RSV illness in infants through vaccination during pregnancy and the consequent positive health implications for children may be a key component of public health and health care strategies to encourage RSV vaccination among pregnant individuals," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

SARS-CoV-2 Vaccine Does Not Increase New-Onset Seizure Risk

TUESDAY, April 30, 2024 -- There is no risk for new-onset seizure incidence for individuals receiving a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine versus...

RSV Burden in Children Under 5 Increased in 2021 and 2022 Versus 2015-2019

FRIDAY, April 19, 2024 -- For children younger than 5 years, the incidence of respiratory syncytial virus (RSV) hospitalization increased in 2021 and 2022 compared with 2015 to...

2011 to 2021 Saw Increase in Vaccination Timeliness for Infants

MONDAY, April 15, 2024 -- From 2011 to 2021, there was an increase in vaccination timeliness among U.S. children aged 0 to 19 months, according to a study published online April...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.